Diseases, Conditions, Syndromes

Saudi Arabia reports one more death from new virus

Saudi Arabia says a man has died from a new respiratory virus related to SARS, bringing to 62 the number of deaths in the kingdom at the center of the outbreak.

Medications

"Evidence is weak" for cold treatment with echinacea

(Medical Xpress)—For people seeking a natural treatment for the common cold, some preparations containing the plant Echinacea work better than nothing, yet "evidence is weak," finds a new report from The Cochrane Library. ...

Health

Preventing and treating the common cold: Nothing to sneeze at

How do you prevent and treat the common cold? Handwashing and zinc may be best for prevention whereas acetaminophen, ibuprofen and perhaps antihistamine–decongestant combinations are the recommended treatments, according ...

Health

Meet Henry the Hand: A crusading doctor's right-hand man

(HealthDay)—When Dr. Will Sawyer, an infection prevention specialist, dropped off his young children at day care in the late 1980s, he saw something most parents rarely notice: germs, and lots of them.

Medical research

Researchers find new rhinovirus infection insights

(Medical Xpress)—On average, each of us catches a cold two to three times a year. However, how the common cold virus actually infects us is only partly understood. Researchers from the Max F. Perutz Laboratories of the ...

Diseases, Conditions, Syndromes

Effectiveness of antiviral nasal spray confirmed

Marinomed Biotechnologie GmbH today announced that new clinical data confirmed the effectiveness of a Carragelose®-based nasal spray in the therapy of common cold. The data, generated in collaboration with researchers from ...

Medical research

Model virus structure shows why there's no cure for common cold

In a pair of landmark studies that exploit the genetic sequencing of the "missing link" cold virus, rhinovirus C, scientists at the University of Wisconsin-Madison have constructed a three-dimensional model of the pathogen ...

Psychology & Psychiatry

Cocaine vaccine passes key testing hurdle

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, ...

page 9 from 14